日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cardiovascular Considerations After Cancer Therapy: Gaps in Evidence and JACC: CardioOncology Expert Panel Recommendations

癌症治疗后心血管方面的考量:证据缺口及JACC:心血管肿瘤学专家组建议

Blaes, Anne; Nohria, Anju; Armenian, Saro; Bergom, Carmen; Thavendiranathan, Paaladinesh; Barac, Ana; Sanchez-Petitto, Gabriela; Desai, Sanjal; Zullig, Leah L; Morgans, Alicia K; Herrmann, Joerg

Outcomes in patients with classic Hodgkin lymphoma refractory or intolerant to brentuximab vedotin and anti-PD-1 therapy: a real world analysis from 15 U.S. academic centers

对布伦妥昔单抗和抗PD-1疗法耐药或不耐受的经典霍奇金淋巴瘤患者的治疗结果:来自15个美国学术中心的真实世界分析

Voorhees, Timothy J; McLaughlin, Eric M; Torka, Pallawi; Florindez, Jorge; Kim, Na Hyun; Moyo, Tamara K; Reves, Heather; Sumransub, Nuttavut; Deshpande, Saarang; Rose, Ashley; Duarte, Cassandra; Faisal, Muhammad Salman; Hamid, Showkat; Subbiah, Suki; Ayyappan, Sabarish; Shea, Lauren; Cortese, Matt; Patel, Krish; Major, Ajay; Saeed, Hayder; Svoboda, Jakub; Desai, Sanjal; Geethakumari, Praveen Ramakrishnan; Hamadani, Mehdi; Grover, Natalie; Epperla, Narendranath

DsDNA breaks inflicted by cell-free chromatin particles selectively target telomeres.

无细胞染色质颗粒造成的双链DNA断裂会选择性地靶向端粒。

Birwatkar Sanjal, Ghosh Tanisha, Selukar Rutuja, Lopes Relestina, Khare Naveen Kumar, Raghuram Gorantla V, Shabrish Snehal, Mittra Indraneel

Checkpoint inhibitor-based salvage regimens prior to autologous stem cell transplant improve event-free survival in relapsed/refractory classic Hodgkin lymphoma

在自体干细胞移植前采用基于免疫检查点抑制剂的挽救治疗方案可改善复发/难治性经典霍奇金淋巴瘤患者的无事件生存期。

Desai, Sanjal H; Spinner, Michael A; David, Kevin; Bachanova, Veronika; Goyal, Gaurav; Kahl, Brad; Dorritie, Kathleen; Azzi, Jacques; Kenkre, Vaishalee P; Arai, Sally; Chang, Cheryl; Fusco, Brendon; Sumransub, Nuttavut; Hatic, Haris; Saba, Raya; Ibrahim, Uroosa; Harris, Elyse I; Shah, Harsh; Murphy, Jacob; Ansell, Stephen; Jagadish, Deepa; Orellana-Noia, Victor; Diefenbach, Catherine; Iyenger, Siddharth; Rappazzo, K C; Mishra, Rahul; Choi, Yun; Nowakowski, Grzegorz S; Advani, Ranjana H; Micallef, Ivana N

Effect of cumulative dose of brentuximab vedotin maintenance in relapsed/refractory classical Hodgkin lymphoma after autologous stem cell transplant: an analysis of real-world outcomes

自体干细胞移植后复发/难治性经典型霍奇金淋巴瘤患者接受布伦妥昔单抗维持治疗累积剂量的效果:一项真实世界结果分析

Wagner, Charlotte B; Boucher, Ken; Nedved, Adrienne; Micallef, Ivana N; Desai, Sanjal; Hatic, Haris; Goyal, Gaurav; Zacholski, Erin; Fegley, Amanda; Sigmund, Audrey M; Bond, David A; Samuels, Courtney; Kamdar, Manali K; Ba Aqeel, Sheeba; Torka, Pallawi; MacDougall, Kira; Borogovac, Azra; Rajeeve, Sridevi; Sundaram, Suchitra; Fedak, Kalub; Modi, Dipenkumar; Travers, Elizabeth; Ayyappan, Sabarish; Chilakamarri, Nitin; Brem, Elizabeth A; Ermann, Daniel A; Fitzgerald, Lindsey A; Hu, Boyu; Stephens, Deborah M; Shah, Harsh

Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era

自体干细胞移植后进展的经典霍奇金淋巴瘤患者的总生存期:新药时代的研究结果

Desai, Sanjal H; Spinner, Michael A; Evens, Andrew M; Sykorova, Alice; Bachanova, Veronika; Goyal, Gaurav; Kahl, Brad; Dorritie, Kathleen; Azzi, Jacues; Kenkre, Vaishalee P; Chang, Cheryl; Michalka, Jozef; Ansell, Stephen M; Fusco, Brendon; Sumransub, Nuttavut; Hatic, Haris; Saba, Raya; Ibrahim, Uroosa; Harris, Elyse I; Shah, Harsh; Wagner-Johnston, Nina; Arai, Sally; Nowakowski, Grzegorz S; Mocikova, Heidi; Jagadeesh, Deepa; Blum, Kristie A; Diefenbach, Catherine; Iyengar, Siddharth; Rappazzo, K C; Baidoun, Firas; Choi, Yun; Prochazka, Vit; Advani, Ranjana H; Micallef, Ivana

PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts

PET2 反应与新诊断弥漫性大 B 细胞淋巴瘤患者的生存率相关:两项独立前瞻性队列研究的结果

Desai, Sanjal H; Pederson, Levi; LaPlant, Betsy; Mwangi, Raphael; Maurer, Matthew; Young, Jason R; Macon, William R; King, Rebecca L; Wang, Yucai; Cerhan, James R; Feldman, Andrew; Inwards, David J; Micallef, Ivana; Johnston, Patrick; Porrata, Luis F; Ansell, Stephen M; Habermann, Thomas M; Witzig, Thomas E; Nowakowski, Grzegorz S

Increasing tissue requirements in lymphoma trials may exclude patients with high-risk disease or worse prognosis

淋巴瘤临床试验中组织样本需求量的增加可能会将高危疾病患者或预后较差的患者排除在外。

Desai, Sanjal H; Mwangi, Raphael; Ng, Wern Lynn; King, Rebecca L; Maurer, Matthew J; Cerhan, James R; Feldman, Andrew L; Farooq, Umar; Mou, Eric; Habermann, Thomas M; Thompson, Carrie A; Wang, Yucai; Witzig, Thomas E; Nowakowski, Grzegorz S

Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma: results from the Phase 2 MC078E study

来那度胺联合 R-CHOP 方案治疗由滤泡性淋巴瘤转化而来的初治弥漫性大 B 细胞淋巴瘤,可获得较高的缓解率和无进展生存期:来自 II 期 MC078E 研究的结果

Desai, Sanjal H; LaPlant, Betsy; Macon, William R; King, Rebecca L; Wang, Yucai; Inwards, David J; Micallef, Ivana; Johnston, Patrick B; Porrata, Luis F; Ansell, Stephen M; Habermann, Thomas M; Witzig, Thomas E; Nowakowski, Grzegorz S

Single-Center Analysis of Characteristics and Outcomes of De Novo, Concurrent, and Transformed Diffuse Large B-Cell Lymphoma

单中心分析原发性、并发性和转化性弥漫性大B细胞淋巴瘤的特征和预后

Desai, Sanjal; Chaturvedi, Mansi; Hameed, Rumaisa; Baez-Sosa, Valentina; Shenoy, Aarthi G